Chronic high dose transdermal nicotine in Parkinson ’ s disease : an open trial

@inproceedings{Villafanea2007ChronicHD,
  title={Chronic high dose transdermal nicotine in Parkinson ’ s disease : an open trial},
  author={G. Villafanea and P. Cesaroa and A. Riallandb and S. Baloulb and S. Azimic and C. Bourdeta and J. Le Houezecd and I. Macquin-Maviere and P. Maisonb},
  year={2007}
}
  • G. Villafanea, P. Cesaroa, +6 authors P. Maisonb
  • Published 2007
G. Villafane, P. Cesaro, A. Rialland, S. Baloul, S. Azimi, C. Bourdet, J. Le Houezec, I. Macquin-Mavier and P. Maison Service de Neurologie, Hôpital Henri Mondor, and unité INSERM U841-NPI, Créteil, France; Unité de Recherche Clinique, CHU Henri Mondor, AP-HP, Université Paris XII, Créteil, France; Direction Régionale de la Recherche Clinique, AP-HP, Hôpital saint Louis, Paris, France; Amzer Glas, Consultant in Public Health, Rennes, France; and Service de Pharmacologie Clinique Hôpital Henri… CONTINUE READING
Highly Cited
This paper has 47 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 22 citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Long-term nicotine administration can improve Parkinson’s disease: report of a case after three years of treatment

  • G Villafane, A Mimran, JD Degos, G Lagrue, P. Cesaro
  • Revista Neurologica Argentina
  • 2002
Highly Influential
2 Excerpts

Long term nicotine treatment in Parkinson’s disease: report of a case

  • G Villafane, JD Degos, G Lagrue, S Petras, P. Cesaro
  • Movement Disorders
  • 2000
Highly Influential
2 Excerpts